Rational Advisors LLC cut its holdings in Centene Corp (NYSE:CNC) by 9.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 11,844 shares of the company’s stock after selling 1,237 shares during the period. Rational Advisors LLC’s holdings in Centene were worth $1,715,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of CNC. Tavio Capital LLC bought a new stake in Centene in the 2nd quarter valued at about $20,773,000. Sentry Investment Management LLC bought a new stake in Centene in the 2nd quarter valued at about $1,679,000. Commonwealth Bank of Australia lifted its position in Centene by 16.3% in the 2nd quarter. Commonwealth Bank of Australia now owns 18,178 shares of the company’s stock valued at $2,234,000 after purchasing an additional 2,554 shares during the last quarter. Schroder Investment Management Group lifted its position in Centene by 274.4% in the 2nd quarter. Schroder Investment Management Group now owns 4,365 shares of the company’s stock valued at $540,000 after purchasing an additional 3,199 shares during the last quarter. Finally, DNB Asset Management AS lifted its position in Centene by 11.5% in the 3rd quarter. DNB Asset Management AS now owns 25,309 shares of the company’s stock valued at $3,664,000 after purchasing an additional 2,609 shares during the last quarter. 89.76% of the stock is owned by institutional investors and hedge funds.

NYSE CNC opened at $136.00 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.03 and a current ratio of 1.03. Centene Corp has a 12 month low of $93.15 and a 12 month high of $148.24. The company has a market capitalization of $27.93 billion, a P/E ratio of 27.04, a price-to-earnings-growth ratio of 1.29 and a beta of 1.05.

Centene (NYSE:CNC) last released its earnings results on Tuesday, October 23rd. The company reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.02. Centene had a net margin of 1.58% and a return on equity of 14.42%. The business had revenue of $16.18 billion for the quarter, compared to the consensus estimate of $15.93 billion. During the same period in the previous year, the firm earned $1.35 EPS. The business’s revenue for the quarter was up 36.0% on a year-over-year basis. On average, research analysts expect that Centene Corp will post 7.05 EPS for the current fiscal year.

In related news, Director Robert K. Ditmore sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, October 25th. The shares were sold at an average price of $129.24, for a total value of $1,938,600.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Keith H. Williamson sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, September 28th. The stock was sold at an average price of $145.00, for a total transaction of $290,000.00. The disclosure for this sale can be found here. Insiders sold a total of 35,800 shares of company stock worth $4,957,590 over the last quarter. Insiders own 3.00% of the company’s stock.

Several analysts recently weighed in on CNC shares. Piper Jaffray Companies reiterated a “buy” rating and issued a $152.00 price objective on shares of Centene in a research report on Wednesday, July 25th. Bank of America lifted their price objective on shares of Centene from $145.00 to $158.00 and gave the company a “buy” rating in a research report on Tuesday, July 24th. Zacks Investment Research upgraded shares of Centene from a “hold” rating to a “buy” rating and set a $152.00 price objective on the stock in a research report on Wednesday, August 8th. Credit Suisse Group lifted their price objective on shares of Centene from $134.00 to $152.00 and gave the company a “neutral” rating in a research report on Tuesday, September 4th. Finally, MED restated an “outperform” rating and set a $146.00 price target (up from $138.00) on shares of Centene in a research report on Wednesday, July 25th. Three equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $151.67.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/19/centene-corp-cnc-holdings-trimmed-by-rational-advisors-llc.html.

Centene Profile

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.

Featured Article: How to calculate the annual rate of depreciation

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corp (NYSE:CNC).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.